Comparing the current results to its competitors, Standard Biotools Inc reported Revenue decrease in the 2 quarter 2026 year on year by -7.05 %, despite the revenue increase by the most of its competitors of 4.44 %, recorded in the same quarter.
Standard Biotools Inc , slower than the average decrease reported by the company's competitors of -1.14 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -1.14 %
Standard Biotools Inc 's Comment on Competition and Industry Peers
The company’s business is influenced by factors such as product sales and shipment timing, business strategies, financing, expansion plans, and investments. Its competitive position and industry environment also impact operations, alongside pressures from NIH funding, U.S. export controls, and tariffs. The company considers growth opportunities and market growth expectations, while managing competition effects and cost optimization. Additionally, it focuses on growth acceleration, potential mergers and acquisitions, restructuring plans, and the integration of acquired businesses.
February 26, 2024
Next Gen Diagnostics and Standard BioTools Partner to Revolutionize Pathogen Sequencing AutomationSOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 - Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose - Unleashing tools to accelerate breakthroughs in human health - and Next Gen Diagnostics have announced a groundbreaking partnership. This long-term agreement aims to revolutionize the automation of sample preparation for pathogen whole genome sequencing, bringing forth a new era of advanced diagnostics.Under this exclusive agreement, Standard BioTools will take the lead in manufacturing the NGD-100, a tailored version of its proprietary microfluidics-based Biomark X9 System, customized specifically for Ne...
Thermo Fisher Scientific Inc operates as a global leader in scientific research and services by delivering an extensive range of high-quality scientific instruments, reagents, consumables, and software solutions tailored to industries such as healthcare, pharmaceuticals, biotechnology, academia, and government. The company enhances its value proposition through a comprehensive suite of services, including laboratory outsourcing, scientific consulting, and data analysis, which help streamline research and development processes for its customers. By leveraging advanced technology and deep industry expertise, Thermo Fisher empowers researchers and organizations to drive innovation and accelerate scientific discovery.
Bio-Rad Laboratories Inc operates as a global leader in life sciences and clinical diagnostics by focusing on the development, manufacturing, and distribution of a diverse array of products and solutions. Their business model emphasizes innovation, providing advanced tools and technologies that empower scientists and healthcare professionals to effectively analyze biological materials. By delivering high-quality solutions, Bio-Rad aims to facilitate scientific breakthroughs and enhance patient care in various healthcare settings.
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Avantor Inc's business model revolves around providing a wide range of products, services, and solutions to customers in the life sciences, advanced technologies, and applied materials sectors. They focus on delivering a comprehensive offering, including chemicals, lab equipment, consumables, and customized solutions, to support research, development, and production processes.
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Sources:
Standard Biotools Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Standard Biotools Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
